When.com Web Search

Search results

1. Results From The WOW.Com Content Network

2. Elle Macpherson Defends Decision to Refuse Chemotherapy ... - AOL

   www.aol.com/elle-macpherson-defends-decision...

   On September 9, the 60-year-old supermodel appeared on Australia’s Today show and responded to the criticism she’s gotten since revealing she was diagnosed with breast cancer seven years ago ...

3. Elle Macpherson reveals she battled breast cancer and ... - AOL

   www.aol.com/elle-macpherson-reveals-she-battled...

   Chemotherapy is an effective treatment that destroys cancer cells and can rid the body of cancer "completely" or help patients have "a better quality of life by reducing symptoms," according to ...

4. Elle Macpherson says she refused chemotherapy after breast ...

   www.aol.com/lifestyle/elle-macpherson-says-she...

   After being diagnosed with breast cancer seven years ago, Elle Macpherson made a controversial choice: She refused chemotherapy, the model has revealed in her new memoir, Elle: Life, Lessons, and ...

5. Bernard Fisher (scientist) - Wikipedia

   en.wikipedia.org/wiki/Bernard_Fisher_(scientist)

   Fisher's impact on breast-cancer treatment was the subject of an August 2013 article in the Atlantic Monthly that was occasioned by his 95th birthday. "Before 1971, if you had breast cancer, chances are you'd have to get your breast cut off", the article recalled. "Surgeons had been taught one thing: radical surgery saves lives.

6. Rose Kushner - Wikipedia

   en.wikipedia.org/wiki/Rose_Kushner

   After Rose Kushner's June 1974 discovery of a cancerous lump in her breast, breast cancer became the focus of her life.On the basis of her library research into breast cancer treatment, she objected to the treatment which was then standard, in which a tumor biopsy and radical mastectomy were performed in a single surgical operation while the patient was under anesthesia.

7. Breast cancer management - Wikipedia

   en.wikipedia.org/wiki/Breast_cancer_management

   Staging breast cancer is the initial step to help physicians determine the most appropriate course of treatment. As of 2016, guidelines incorporated biologic factors, such as tumor grade, cellular proliferation rate, estrogen and progesterone receptor expression, human epidermal growth factor 2 (HER2) expression, and gene expression profiling into the staging system.